The US Food and Drug Administration (FDA) ordered the Johnson & Johnson company to discard 60 million doses of its anti-COVID vaccine that were produced during the incident at a factory in the US city of Baltimore, where a part of the drugs was contaminated.
It was reported earlier that at an Emergent BioSolutions company factory in Baltimore the ingredients of two different coronavirus vaccines were confused, and that 15 million doses of Johnson & Johnson’s vaccine were spoiled as a result.
- Study reveals the harmful side effect of fasting
- A popular breakfast food that increases Diabetes risk by 60 percent, according to experts
- This is how flies are tricked into choosing healthier foods (and it may work in humans)
- Low levels of this vitamin may lead to Opioid addiction
- Vitamin D: Why it is so essential for immune response?
“Federal regulators told Johnson & Johnson that around 60 million doses of its coronavirus vaccine produced in the troubled Baltimore factory cannot be used due to possible contamination,” according to the sources.
The US medical regulator plans to authorize the use of some 10 million doses of this vaccine both domestically and for export while stressing that it cannot guarantee that those doses have not been contaminated.
The possibility of reopening the plant in Baltimore is still pending.
In contrast to the other corona vaccines approved to date, the Johnson & Johnson vaccine only requires one injection syringe for comprehensive protection.
In addition, storage and delivery are comparatively easy. The J&J vaccine was therefore increasingly used in the USA and is also intended to help accelerate vaccination campaigns in the EU.
Photo by Matthias Bein/picture alliance via Getty Images